Santarus Announces Presentation of UCERIS Phase III Extended Use Data at ...
MarketWatch (press release)
Santarus(R), FENOGLIDE(R), UCERIS(TM), and ZEGERID(R) are trademarks of Santarus, Inc. GLUMETZA(R) is a trademark of Biovail Laboratories International Srl licensed exclusively in the United States to Depomed, Inc. CYCLOSET(R) is a trademark of ...

und weitere »

Covington & Burling | Covington Scores Antitrust Defense Victory for Valeant
Linex Legal (press release) (registration)
Plaintiffs alleged that Biovail filed sham patent cases against four generic drug manufacturers and also filed a sham Citizen Petition with the FDA that allegedly delayed the marketing of generic versions of Wellbutrin XL. Judge Mary A. McLaughlin ...

Cortex Reports First Quarter Operating Results
EON: Enhanced Online News (press release)
Along with the $200000 upfront payment related to the March 2011 transaction with Biovail, the decreased operating expenses reflect the Company's previously announced decrease in its internal staffing levels in its efforts to conserve its financial ...

und weitere »

Cortex Reports First Quarter Operating Results
MarketWatch (press release)
Along with the $200000 upfront payment related to the March 2011 transaction with Biovail, the decreased operating expenses reflect the Company's previously announced decrease in its internal staffing levels in its efforts to conserve its financial ...

und weitere »

BlackBerry maker no longer Canada's most valuable tech company
Waterloo Record
Valeant, formed through a merger with Mississauga's Biovail Corp. in 2010, has seen revenue triple since 2008, largely on the strength of acquisitions. While RIM's market cap tumbled over the past twelve months its revenue has pulled back only modestly ...

und weitere »

DataTrans Solutions Welcomes Kenrick Roberts to Support Team
Virtual-Strategy Magazine
He then moved into the healthcare distribution space supporting EDI for Biovail with trading partners that included McKesson, and Owens & Minor. Most recently, Kenrick expanded his experience in the banking industry with the Bank of Montreal and with ...

und weitere »

Valeant Beats, Raises EPS Outlook
Zacks.com
Valeant Pharma, as it stands today, was formed following the merger of Biovail and Valeant in September 2010. We believe that the combined Biovail/Valeant entity is a unique company as it has a global reach (including exposure to important emerging ...
Morgan Stanley Raises Price Target on Valeant Pharmaceuticals (VRX)Junction Report

Alle 5 Artikel »

Acquisition spree muddies Valeant's financial trajectory
Globe and Mail
In a sign of just how far Valeant has evolved since it merged with Biovail Corp. in 2010, the company pointed out that several of the key legacy neurology products it inherited from the Biovail portfolio are now in decline.
Valeant to acquire acne medicine, posts Q1 loss due to variety of factorsCanadianBusiness.com

Alle 13 Artikel »

Valeant: A Risky Bet For Brave Investors
Seeking Alpha
Another major building block was added in 2010 when Biovail took over Valeant but kept the Valeant name for the merged company. Since the merger, the company has taken over PharmaSwiss SA., Dermik [the dermatology of unit of Sanofi (SNY)], ...
Valeant Pharmaceuticals Reports 2012 First Quarter Financial ResultsMarketWatch (press release)
Valeant posts 1Q loss on dermatology deal costsBusinessWeek
Valeant to acquire acne medicine, posts first quarter lossCTV.ca

Alle 58 Artikel »

NHL: Senators Owner Fires First Shots In Erik Karlsson Sweepstakes
Sports Interaction
As founder of the specialty pharmaceutical giant Biovail Corporation, he's accustomed to not only getting what he wants but getting it at a good price too. Along with a horse-racing stable in Florida, Melnyk is also the owner of two small-market hockey ...

und weitere »